secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2021-10-29T23:59:59+00:00
Accession:  0001628280-21-020884
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex director Tony Lau resigns; Champion River to nominate successor
-------------------------------------------------------------------------

- Tony Lau notified ChromaDex of his resignation from the Board and Compensation Committee on Oct 19, 2021; effective date not yet determined.
- Resignation not due to any disagreement with the company; follows Lau's resignation from his position at Horizon Ventures.
- Champion River Ventures, which nominated Lau, intends to nominate a replacement director under the 2017 Securities Purchase Agreement.
- Lau's departure is unrelated to company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/0001628280-21-020884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/cdxc-20211019.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-020884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer